Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion type Assertion NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_head.
- NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion description "[Increased abundance of ?II- and ?III-tubulin isotypes in cancer cells confers resistance to vinca and taxoid site drugs; however, the role of these isotypes in the acquired resistance of cancer cells to non-vinca or non-taxoid site binding agents has not been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_provenance.
- NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion evidence source_evidence_literature NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_provenance.
- NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion SIO_000772 22180309 NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_provenance.
- NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion wasDerivedFrom befree-20150227 NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_provenance.
- NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_assertion wasGeneratedBy ECO_0000203 NP889393.RAFOdmOdKVnNissO7Mj9NTjQyKzNnAEBWCrF2wF_g1ucA130_provenance.